Ron Gansevoort: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Levin, Adeera, Tonelli, Marcello, Bonventre, Joseph, Coresh, Josef, Donner, Jo-Ann, Fogo, Agnes B, Fox, Caroline S, Gansevoort, Ron T, Heerspink, Hiddo J L, Jardine, Meg, Kasiske, Bertram, Köttgen, An

Journal:

Year:

2017

Language:

english

File:

PDF, 950 KB

english, 2017

2

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Heerspink, Hiddo J L, Greene, Tom, Tighiouart, Hocine, Gansevoort, Ron T, Coresh, Josef, Simon, Andrew L, Chan, Tak Mao, Hou, Fan Fan, Lewis, Julia B, Locatelli, Francesco, Praga, Manuel, Schena, Fran

Journal:

The Lancet Diabetes & Endocrinology

Year:

2019

Language:

english

File:

PDF, 894 KB

english, 2019

3

Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a

Jan Willem Haveman, Ron T. Gansevoort, Alfons H. H. Bongaerts, Maarten W. N. Nijsten

Journal:

Intensive Care Medicine

Year:

2006

Language:

english

File:

PDF, 197 KB

english, 2006

4

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study

Vicente E. Torres, Esther Meijer, Kyongtae T. Bae, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham, Eiji Higashihara, Ronald D. Perrone, Holly B. Krasa, John J. Ouyang, Frank

Journal:

American Journal of Kidney Diseases

Year:

2011

Language:

english

File:

PDF, 418 KB

english, 2011

5

Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria: Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT)

Frank P. Brouwers, Folkert W. Asselbergs, Hans L. Hillege, Rudolf A. de Boer, Ron T. Gansevoort, Dirk J. van Veldhuisen, Wiek H. van Gilst

Journal:

American Heart Journal

Year:

2011

Language:

english

File:

PDF, 178 KB

english, 2011

6

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Grantham, Jared J., Higashihara, Eiji, Perrone, Ronald D., Krasa, Holly B., Ouyang, John, Czerwiec, Frank S.

Journal:

Boston Medical and Surgical Journal

Year:

2012

Language:

english

File:

PDF, 897 KB

english, 2012

7

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

Gansevoort, Ron T, Correa-Rotter, Ricardo, Hemmelgarn, Brenda R, Jafar, Tazeen H, Heerspink, Hiddo J Lambers, Mann, Johannes F, Matsushita, Kunihiro, Wen, Chi Pang

Journal:

Year:

2013

Language:

english

File:

PDF, 1.10 MB

english, 2013

8

Alcohol consumption is inversely associated with the risk of developing chronic kidney disease

Koning, Sarah H, Gansevoort, Ron T, Mukamal, Kenneth J, Rimm, Eric B, Bakker, Stephan J L, Joosten, Michel M

Journal:

Kidney International

Year:

2015

Language:

english

File:

PDF, 198 KB

english, 2015

9

Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?

Casteleijn, Niek F., Zittema, Debbie, Bakker, Stephan J.L., Boertien, Wendy E., Gaillard, Carlo A., Meijer, Esther, Spithoven, Edwin M., Struck, Joachim, Gansevoort, Ron T.

Journal:

American Journal of Nephrology

Year:

2015

Language:

english

File:

PDF, 164 KB

english, 2015

10

Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease

Liu, Licette CY, Schutte, Elise, Gansevoort, Ron T, van der Meer, Peter, Voors, Adriaan A

Journal:

Expert Opinion on Investigational Drugs

Year:

2015

Language:

english

File:

PDF, 656 KB

english, 2015

11

Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial

Gansevoort, Ron T., Meijer, Esther, Chapman, Arlene B., Czerwiec, Frank S., Devuyst, Olivier, Grantham, Jared J., Higashihara, Eiji, Krasa, Holly B., Ouyang, John, Perrone, Ronald D., Torres, Vicente

Journal:

Nephrology Dialysis Transplantation

Year:

2015

Language:

english

File:

PDF, 288 KB

english, 2015

12

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Gansevoort, Ron T., Arici, Mustafa, Benzing, Thomas, Birn, Henrik, Capasso, Giovambattista, Covic, Adrian, Devuyst, Olivier, Drechsler, Christiane, Eckardt, Kai-Uwe, Emma, Francesco, Knebelmann, Bertr

Journal:

Nephrology Dialysis Transplantation

Year:

2016

Language:

english

File:

PDF, 673 KB

english, 2016

13

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease

Grantham, Jared J., Chapman, Arlene B., Blais, Jaime, Czerwiec, Frank S., Devuyst, Olivier, Gansevoort, Ron T., Higashihara, Eiji, Krasa, Holly, Zhou, Wen, Ouyang, John, Perrone, Ronald D., Torres, Vi

Journal:

Nephrology Dialysis Transplantation

Year:

2016

Language:

english

File:

PDF, 366 KB

english, 2016

14

Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease

Zittema, Debbie, Versteeg, Irina B., Gansevoort, Ron T., van Goor, Harry, de Heer, Emile, Veraar, Kimberley A.M., Peters, Dorien J.M., Meijer, Esther

Journal:

American Journal of Nephrology

Year:

2016

Language:

english

File:

PDF, 252 KB

english, 2016

15

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial

Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Perrone, Ronald D., Dandurand, Ann, Ouyang, John, Czerwiec, Frank S., Blais, Jaime D.

Journal:

Nephrology Dialysis Transplantation

Year:

2017

Language:

english

File:

PDF, 2.59 MB

english, 2017

16

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

Cornec-Le Gall, Emilie, Blais, Jaime D., Irazabal, Maria V., Devuyst, Olivier, Gansevoort, Ron T., Perrone, Ron D., Chapman, Arlene B., Czerwiec, Frank S., Ouyang, John, Heyer, Christina M., Senum, Sa

Journal:

Nephrology Dialysis Transplantation

Year:

2017

Language:

english

File:

PDF, 279 KB

english, 2017

17

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Perrone, Ronald D., Koch, Gary, Ouyang, John, McQuade, Robert D., Blais, Jaime D., Czerwiec, Frank S., Sergeyeva, Olga

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 385 KB

english, 2017

18

Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population

Suthahar, Navin, Meijers, Wouter C., Ho, Jennifer E., Gansevoort, Ron T., Voors, Adriaan A., van der Meer, Peter, Bakker, Stephan J.L., Heymans, Stephane, van Empel, Vanessa, Schroen, Blanche, van der

Journal:

European Journal of Heart Failure

Year:

2018

Language:

english

File:

PDF, 541 KB

english, 2018

19

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

Inker, Lesley A., Heerspink, Hiddo J. L., Tighiouart, Hocine, Levey, Andrew S., Coresh, Josef, Gansevoort, Ron T., Simon, Andrew L., Ying, Jian, Beck, Gerald J., Wanner, Christoph, Floege, Jürgen, Li,

Journal:

Journal of the American Society of Nephrology

Year:

2019

Language:

english

File:

PDF, 712 KB

english, 2019

20

Use of copeptin in the diagnosis of polyuria-polydipsia syndrome

Heida, Judith E, Gansevoort, Ron T, van Beek, André P

Journal:

Lancet (London, England)

Year:

2020

Language:

english

File:

PDF, 151 KB

english, 2020

21

Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review

Sautenet, BÃ©nÃ©dicte, Cho, Yeoungjee, Gutman, Talia, Rangan, Gopala, Ong, Albert, Chapman, Arlene B., Ahn, Curie, Coolican, Helen, Tze-Wah Kao, Juliana, Fowler, Kevin, Gansevoort, Ron T., Geneste, Cl

Journal:

American Journal of Kidney Diseases

Year:

2020

File:

PDF, 2.49 MB

2020

22

Oxidative Stress Is Associated with Suspected NonâAlcoholic Fatty Liver Disease and AllâCause Mortality in the General Population

Damba, Turtushikh, Bourgonje, Arno R., Abdulle, Amaal E., Pasch, Andreas, Sydor, Svenja, van den Berg, Eline H., Gansevoort, Ron T., Bakker, Stephan J.L., Blokzijl, Hans, Dullaart, Robin P.F., van Goo

Journal:

Liver International

Year:

2020

File:

PDF, 863 KB

2020

23

External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study

Ali Abbasi, Eva Corpeleijn, Linda M. Peelen, Ron T. Gansevoort, Paul E. de Jong, Rijk O. B. Gans, Wolfgang Rathmann, Bernd Kowall, Christine Meisinger, Hans L. Hillege, Ronald P. Stolk, Gerjan Navis,

Journal:

European Journal of Epidemiology

Year:

2012

Language:

english

File:

PDF, 211 KB

english, 2012

24

Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?

Stephan J. L. Bakker, Ron T. Gansevoort, Erik M. Stuveling, Rijk O. B. Gans, Dick de Zeeuw

Journal:

Current Hypertension Reports

Year:

2005

Language:

english

File:

PDF, 328 KB

english, 2005

25

Albuminuria: What can we expect from the determination of nonimmunoreactive albumin?

Stephan J. L. Bakker, Ron T. Gansevoort, Dick de Zeeuw

Journal:

Current Hypertension Reports

Year:

2009

Language:

english

File:

PDF, 358 KB

english, 2009

26

The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate

Jarir Atthobari, Ron T. Gansevoort, Sipke T. Visser, Paul E. De Jong, Lolkje T. W. De Jong-van den Berg, the PREVEND study group

Journal:

British Journal of Clinical Pharmacology

Year:

2007

Language:

english

File:

PDF, 120 KB

english, 2007

27

The effect of screening for cardio-renal risk factors on drug use in the general population

Jarir Atthobari, Ron T. Gansevoort, Sipke T. Visser, Paul E. De Jong, Lolkje T. W. De Jong-van den Berg, PREVEND study group

Journal:

British Journal of Clinical Pharmacology

Year:

2007

Language:

english

File:

PDF, 437 KB

english, 2007

28

Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events

Cornelis Boersma, Maarten J. Postma, Sipke T. Visser, Jarir Atthobari, Paul E. De Jong, Lolkje T. W. De Jong-van den Berg, Ron T. Gansevoort, PREVEND Study Group

Journal:

British Journal of Clinical Pharmacology

Year:

2008

Language:

english

File:

PDF, 787 KB

english, 2008

29

Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study

Inge M. van Schouwenburg, Bakhtawar K. Mahmoodi, Nic J. G. M. Veeger, Hanneke C. Kluin-Nelemans, Ron T. Gansevoort, Karina Meijer

Journal:

British Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 103 KB

english, 2012

30

Inflammation reduces HDL protection against primary cardiac risk

James P. Corsetti, Ron T. Gansevoort, Charles E. Sparks, Robin P. F. Dullaart

Journal:

European Journal of Clinical Investigation

Year:

2010

Language:

english

File:

PDF, 252 KB

english, 2010

31

Prevention of chronic kidney disease: The next step forward! (Review Article)

PAUL E DE JONG, RON T GANSEVOORT

Journal:

Year:

2006

Language:

english

File:

PDF, 73 KB

english, 2006

32

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population

Verhave, Jacobien C., Gansevoort, Ron T., Hillege, Hans L., Bakker, Stephan J.L., De Zeeuw, Dick, de Jong, Paul E.

Journal:

Kidney International

Year:

2004

Language:

english

File:

PDF, 81 KB

english, 2004

33

Trends in the incidence of treated end-stage renal failure in The Netherlands: Hope for the future?

Gansevoort, Ron T., van der Heij, Bart, Stegeman, Coen A., de Charro, Frank T., Nieuwenhuizen, Martin G., de Zeeuw, Dick, de Jong, Paul E.

Journal:

Kidney International

Year:

2004

Language:

english

File:

PDF, 91 KB

english, 2004

34

Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC

Brinkman, Jacoline W., Bakker, Stephan J.L., Gansevoort, Ron T., Hillege, Hans L., Kema, Ido P., Gans, Reinold O.B., de Jong, Paul E., de Zeeuw, Dick

Journal:

Kidney International

Year:

2004

Language:

english

File:

PDF, 138 KB

english, 2004

35

Electrocardiographic abnormalities and uremic cardiomyopathy

Stewart, Graham A., Gansevoort, Ron T., Mark, Patrick B., Rooney, Esther, McDonagh, Theresa A., Dargie, Henry J., Stuart, R., Rodger, C., Jardine, Alan G.

Journal:

Kidney International

Year:

2005

Language:

english

File:

PDF, 162 KB

english, 2005

36

The association between atherosclerotic risk factors and renal function in the general population

Verhave, Jacobien C., Hillege, Hans L., Burgerhof, Johannes G.M., Gansevoort, Ron T., Zeeuw, Dick de, Jong, Paul E. De

Journal:

Kidney International

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

37

The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population

Gansevoort, Ron T., Verhave, Jacobien C., Hillege, Hans L., Burgerhof, Johannes G.M., Bakker, Stephan J.L., de Zeeuw, Dick, de Jong, Paul E.

Journal:

Kidney International

Year:

2005

Language:

english

File:

PDF, 126 KB

english, 2005

38

Role of elevated lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients

Dullaart, Robin PF, Gansevoort, Ron T, Dikkeschei, Bert D, de Zeeuw, Dick, de Jong, Paul E, van Tol, Arie

Journal:

Kidney International

Year:

1993

Language:

english

File:

PDF, 669 KB

english, 1993

39

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

Gansevoort, Ron T, de Zeeuw, Dick, de Jong, Paul E

Journal:

Kidney International

Year:

1993

Language:

english

File:

PDF, 592 KB

english, 1993

40

Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?

Gansevoort, Ron T, de Zeeuw, Dick, de Jong, Paul E

Journal:

Kidney International

Year:

1994

Language:

english

File:

PDF, 846 KB

english, 1994

41

Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition

Hemmelder, Marc H, Zeeuw, Dick de, Gansevoort, Ron T, de Jong, Paul E

Journal:

Kidney International

Year:

1996

Language:

english

File:

PDF, 639 KB

english, 1996

42

Relation of Aortic Valve and Coronary Artery Calcium in Patients With Chronic Kidney Disease to the Stage and Etiology of the Renal Disease

Lieuwe H. Piers, Hugo R.W. Touw, Ron Gansevoort, Casper F.M. Franssen, Matthijs Oudkerk, Felix Zijlstra, René A. Tio

Journal:

The American Journal of Cardiology

Year:

2009

Language:

english

File:

PDF, 208 KB

english, 2009

43

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: Cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands

Cornelis Boersma, Ron T. Gansevoort, Petros Pechlivanoglou, Sipke T. Visser, Flip F.J. van Toly, Lolkje T.W. de Jong-van den Berg, Paul E. de Jong, Maarten J. Postma

Journal:

Clinical Therapeutics

Year:

2010

Language:

english

File:

PDF, 151 KB

english, 2010

44

Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein

James P. Corsetti, Ron T. Gansevoort, Stephan J.L. Bakker, GerJan Navis, Charles E. Sparks, Robin P.F. Dullaart

Journal:

Year:

2012

Language:

english

File:

PDF, 320 KB

english, 2012

45

What to Measure—Albuminuria or Total Proteinuria?

Paul E. de Jong, Stephan J.L. Bakker, Ron T. Gansevoort

Journal:

American Journal of Kidney Diseases

Year:

2011

Language:

english

File:

PDF, 130 KB

english, 2011

46

Albuminuria, Proteinuria, and Novel Urine Biomarkers as Predictors of Long-term Allograft Outcomes in Kidney Transplant Recipients

Ferdau L. Nauta, Stephan J.L. Bakker, Wim van Oeveren, Gerjan Navis, Jaap J. Homan van der Heide, Harry van Goor, Paul E. de Jong, Ron T. Gansevoort

Journal:

American Journal of Kidney Diseases

Year:

2011

Language:

english

File:

PDF, 1.01 MB

english, 2011

47

In Reply to 'Albuminuria, Proteinuria, and Graft Survival in Kidney Transplantation'

Ferdau L. Nauta, Stephan J.L. Bakker, Ron T. Gansevoort

Journal:

American Journal of Kidney Diseases

Year:

2011

Language:

english

File:

PDF, 157 KB

english, 2011

48

Effect of Frozen Storage on Urinary Concentration of Kidney Damage Markers

Ferdau L. Nauta, Stephan J.L. Bakker, Hiddo Lambers Heerspink, Dick de Zeeuw, Wim van Oeveren, Henk Bilo, Paul E. de Jong, Ron T. Gansevoort

Journal:

American Journal of Kidney Diseases

Year:

2012

Language:

english

File:

PDF, 286 KB

english, 2012

49

Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy

Tom D.J. Smilde, Folkert W. Asselbergs, Hans L. Hillege, Adriaan A. Voors, Jan A. Kors, Ron T. Gansevoort, Wiek H. van Gilst, Paul E. de Jong, Dirk J. Van Veldhuisen

Journal:

American Journal of Hypertension

Year:

2005

Language:

english

File:

PDF, 178 KB

english, 2005

50

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Jarir Atthobari, Folkert W. Asselbergs, Cornelis Boersma, Robin de Vries, Hans L. Hillege, Wiek H. van Gilst, Ron T. Gansevoort, Paul E. de Jong, Lolkje T.W. de Jong-van den Berg, Maarten J. Postma

Journal:

Clinical Therapeutics

Year:

2006

Language:

english

File:

PDF, 1.50 MB

english, 2006

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски